A carregar...

Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model

AFN-1252, a new antimicrobial agent, specifically and potently inhibits fatty acid synthesis in Staphylococcus aureus. We characterized in vivo pharmacokinetic and pharmacodynamic profiles of AFN-1252 administered orally to neutropenic mice inoculated in thighs (∼10(6) CFU) with methicillin-suscepti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Banevicius, Mary A, Kaplan, Nachum, Hafkin, Barry, Nicolau, David P
Formato: Artigo
Idioma:Inglês
Publicado em: Maney Publishing 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3558988/
https://ncbi.nlm.nih.gov/pubmed/23433441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1179/1973947812Y.0000000061
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!